DRRX

Summary

96% technical buy signals.

242.85+ Weighted Alpha.

142.39% gain in the last year.

The Chart of the Day belongs to Durect (DRRX).   I found the drug stock by using Barchart to sort today's Top Stocks to Own list first by the highest number of new highs in the last month, then I used the Flipchart feature to review the charts for consistent price appreciation.  Since the Trend Spotter signaled a buy on 2/26 the stock gained 85.83%.

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.

DRRX

Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 19 new highs and up 99.11% in the last month
  • Relative Strength Index 92.29%
  • Technical support level at 2.16

Fundamental factors:

  • Market Cap $336 million
  • Revenue expected to decrease by 28.40% this year and another 15.80% next year
  • Earnings estimated to increase 9.10% this year and continue to compound at an annual rate of 20.00% for the next 5 years
  • In spite of these projections Wall Street analysts issued 1 buy and 2 hold recommendations on the stock